Skip to main content

Investors rush into biotechs working on coronavirus vaccine

Some biotech firms have been outperforming the market over the past few weeks on their treatment initiatives.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.